Induction or prevention of intimal hyperplasia by photodynamic therapy in a porcine model

Photodynamic therapy (PDT) has been proposed as a treatment for intimal hyperplasia (IH). We studied the effect of PDT on the development of IH following endothelial injury, using the photosensitizer Metatetrahydroxyphenyl-chlorin (m-THPC) and 652 nm illumination. 9 mini- pigs were used in 3 groups of 3. Pigs in the first group (balloon alone; BA) were anaesthetized and the lower 4 cm of abdominal aorta was denuded using a balloon catheter through the right femoral artery. In the second group (light alone; LA) the procedure was repeated, followed by illumination of the denuded area at an energy density of 20 Jcm-2 using a transparent PDT catheter. In the third group pigs were sensitized and an intravenous injection of 0.3 mg/kg of m-THPC 4 hours prior to balloon injury and illumination (PDT Group). Animals were allowed to recover for 8 weeks before being killed and perfusion fixed with 10% formal saline. 5 sections were cut from the treated segments and stained for elastin. Specimens were measured by a computerized morphometry system and the areas of the lumen (L), intima (I) and media (M) were measured. The degree of intimal hyperplasia was expressed as (a) I/M; (b) I/(I+M) and (c) I/(I+L) to take account of changes that could have occurred to the media and the overall diameter of the vessel. We found that when compared to BA controls, the lumenal area was decreased by 46% in LA group and increased by 44% in PDT group. The changes in the medical areas were minimal. These results show that both light alone and PDT produced more intimal hyperplasia than balloon injury alone (P < 0.002 for both groups, Student's t test). When allowance is made for the large increase in lumenal area associated with PDT the degree of intimal hyperplasia I/(I+L) was significantly reduced in PDT treated vessels when compared to those treated with light and balloon alone in spite of the greater absolute area of the intima in the PDT group. We conclude that PDT under the above conditions not only failed to prevent IH, but was associated with a significant increase of intimal area. The increase in the dimensions of the PDT treated vessels reduced the detrimental effect of IH and improved the overall diameter of the lumen.

[1]  R. Virmani,et al.  Morphogenesis and clinicopathologic characteristics of recurrent carotid disease. , 1986, Journal of vascular surgery.

[2]  F. Cross,et al.  Photodynamic therapy in a cell culture model of human intimal hyperplasia. , 1995, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[3]  T J Flotte,et al.  Photodynamic therapy of arteries. A novel approach for treatment of experimental intimal hyperplasia. , 1992, Circulation.

[4]  P. Hagen,et al.  Altered catecholamine receptor affinity in rabbit aortic intimal hyperplasia. , 1991, The Journal of surgical research.

[5]  J. Mayo,et al.  Coronary angioplasty after coronary bypass surgery: initial results and late outcome in 422 patients. , 1990, Journal of the American College of Cardiology.

[6]  K. Cross,et al.  Reduction of Intimal Hyperplasia and Enhanced Reactivity of Experimental Vein Bypass Grafts with Verapamil Treatment , 1990, Annals of surgery.

[7]  Michael Simons,et al.  Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo , 1992, Nature.

[8]  L. Hillis,et al.  Restenosis after coronary balloon angioplasty. , 1991, Annual review of medicine.

[9]  D. Kessel,et al.  PORPHYRIN ACCUMULATION BY ATHEROMATOUS PLAQUES OF THE AORTA , 1984, Photochemistry and photobiology.

[10]  G. Vincent,et al.  In vivo photosensitizer-enhanced laser angioplasty in atherosclerotic Yucatan miniswine. , 1990, Journal of clinical laser medicine & surgery.

[11]  R. Kempczinski Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty , 1987 .

[12]  W S Moore,et al.  Inhibition of intimal hyperplasia by photodynamic therapy using photofrin. , 1992, The Journal of surgical research.

[13]  R. Ross Mechanisms of smooth muscle profileration—the role of cytikines and growth factors: Research initiatives in vascular surgery * , 1989 .

[14]  H. Baumgartner,et al.  Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. , 1989, Science.

[15]  S Paulin,et al.  Fluorescence of experimental atheromatous plaques with hematoporphyrin derivative. , 1983, The Journal of clinical investigation.

[16]  J. H. Cooper,et al.  Cod-liver oil in the prevention of intimal hyperplasia in autogenous vein grafts used for arterial bypass. , 1985, The Journal of thoracic and cardiovascular surgery.

[17]  M. Todd,et al.  Preventing intimal hyperplasia with photodynamic therapy using an intravascular probe , 1995, Annals of vascular surgery.

[18]  P. Dartsch,et al.  Responses of cultured smooth muscle cells from human nonatherosclerotic arteries and primary stenosing lesions after photoradiation: implications for photodynamic therapy of vascular stenoses. , 1990, Journal of the American College of Cardiology.

[19]  Y. Hsiang,et al.  DETERMINING THE OPTIMAL DOSE OF PHOTOFRIN® IN MINISWINE ATHEROSCLEROTIC PLAQUE , 1993, Photochemistry and photobiology.

[20]  R. Crystal,et al.  Efficient and Selective Adenovirus‐Mediated Gene Transfer Into Vascular Neointima , 1993, Circulation.

[21]  W. Moore,et al.  Patency and intimal hyperplasia: the effect of aspirin on small arterial anastomosis. , 1988, Annals of vascular surgery.

[22]  Spencer B. King,et al.  Restenosis After Coronary Angioplasty: Potential Biologic Determinants and Role of Intimal Hyperplasia , 1989 .

[23]  A. Mansfield,et al.  Efficacy of corticosteroids in suppression of intimal hyperplasia. , 1990, Journal of vascular surgery.

[24]  A. Nicolaides,et al.  Graft stenosis: Justification for 1 ‐year surveillance , 1990, The British journal of surgery.

[25]  J. Schneider,et al.  Hematoporphyrin uptake in atherosclerotic plaques: therapeutic potentials. , 1988, Neurosurgery.

[26]  B. Thiele,et al.  Cyclosporine inhibits the development of medial thickening after experimental arterial injury. , 1990, Journal of vascular surgery.